Hospital
Allina Health System
Allina Health System was paid $26.95M by Medicaid between Jan 2018 and Dec 2024, across 160 billing codes. Its largest line is 99284, emergency room visit (serious) — 50% of everything it billed.
33Billing provider infoALLINA HEALTH SYSTEM
MINNEAPOLIS, MN 55407
MINNEAPOLIS, MN 55407
33aNPI1760446256assigned 04/13/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$26.95M
24GClaims372,023
24DCodes billed160
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Minnesota
Rank by total paid#9 of 36
Median peer was paid$11.46M
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 50,244 | $1.84M | |
| 2019 | 50,717 | $3.77M | |
| 2020 | 38,462 | $2.94M | |
| 2021 | 56,155 | $4.26M | |
| 2022 | 75,168 | $5.66M | |
| 2023 | 60,440 | $4.78M | |
| 2024incomplete | 40,837 | $3.69M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 50% | 49,987 | 47,591 | $13.48M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 22,054 | 20,784 | $3.60M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.6% | 20,135 | 9,217 | $1.23M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4.5% | 23,280 | 19,744 | $1.21M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.7% | 3,287 | 2,958 | $998K |
| 36415 | Collection of venous blood by venipuncture | 2.0% | 48,944 | 42,854 | $530K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.5% | 5,946 | 1,236 | $405K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 5,284 | 4,815 | $391K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.4% | 3,747 | 2,800 | $371K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.3% | 21,539 | 19,600 | $344K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1.2% | 228 | 175 | $315K |
| 85027 | <1% | 19,553 | 18,295 | $263K |
148 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12,203 | $252K |
| G0378 | Hospital observation service, per hour | <1% | 1,343 | $213K |
| 99223 | Prolong inpt eval add15 m | <1% | 1,466 | $196K |
| Q3014 | Telehealth originating site facility fee | <1% | 7,232 | $191K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 3,995 | $190K |
| 80053 | Comprehensive metabolic panel | <1% | 6,393 | $172K |
| 97113 | <1% | 3,151 | $170K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 824 | $158K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 4,376 | $140K |
| 90870 | <1% | 519 | $118K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 451 | $109K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 832 | $105K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,074 | $100K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 3,133 | $86K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,658 | $82K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 65 | $80K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 310 | $78K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 1,056 | $75K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 445 | $67K |
| 97162 | <1% | 2,381 | $61K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 4,529 | $60K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,601 | $52K |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | <1% | 186 | $49K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 1,998 | $46K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 399 | $37K |
| 97161 | <1% | 1,569 | $36K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,108 | $34K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 154 | $32K |
| H2012 | Behavioral health day treatment, per hour | <1% | 179 | $32K |
| 97602 | <1% | 567 | $29K | |
| 90868 | <1% | 271 | $28K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 88 | $28K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 595 | $26K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 169 | $26K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 946 | $25K |
| 99254 | <1% | 204 | $22K | |
| 81001 | <1% | 2,491 | $22K | |
| 82565 | <1% | 2,018 | $22K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 14 | $20K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 4,555 | $19K |
| 99255 | <1% | 138 | $18K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 247 | $18K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,135 | $18K |
| 95886 | <1% | 308 | $17K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,890 | $17K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 481 | $17K |
| 59510 | <1% | 17 | $17K | |
| 97116 | <1% | 529 | $16K | |
| 90837 | Psychotherapy session, about an hour | <1% | 458 | $15K |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 7,294 | $14K |
| 76818 | <1% | 95 | $14K | |
| 83880 | <1% | 1,254 | $13K | |
| 59025 | Fetal non-stress test | <1% | 229 | $13K |
| 96376 | <1% | 47 | $13K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 172 | $13K |
| 71045 | Radiologic examination, chest; single view | <1% | 264 | $12K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,702 | $11K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 151 | $11K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 405 | $11K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 804 | $11K |
| 99253 | <1% | 146 | $11K | |
| 82248 | <1% | 2,913 | $10K | |
| 99221 | <1% | 151 | $10K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 61 | $10K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 134 | $9K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 757 | $9K |
| 83690 | <1% | 2,487 | $8K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 57 | $8K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,335 | $8K |
| 84512 | <1% | 1,166 | $7K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 172 | $7K |
| 99460 | <1% | 97 | $7K | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,251 | $7K |
| 84484 | <1% | 2,121 | $6K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 82 | $6K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 76 | $6K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 106 | $5K |
| 97542 | <1% | 76 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,309 | $5K |
| 85610 | <1% | 1,616 | $4K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 13 | $4K |
| 64644 | <1% | 12 | $4K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 371 | $4K |
| 84132 | <1% | 947 | $4K | |
| 76827 | <1% | 28 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 895 | $4K |
| 71250 | <1% | 14 | $4K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,918 | $4K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,548 | $3K |
| 83735 | <1% | 1,387 | $3K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 80 | $3K |
| 96133 | <1% | 13 | $3K | |
| 81025 | <1% | 324 | $3K | |
| 82803 | <1% | 175 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 893 | $2K |
| 84295 | <1% | 281 | $2K | |
| J0475 | Injection, baclofen, 10 mg | <1% | 26 | $2K |
| 76825 | <1% | 13 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 13 | $2K |
| 82947 | <1% | 146 | $2K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 330 | $2K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 41 | $2K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 51 | $2K |
| 84520 | <1% | 147 | $2K | |
| 93325 | <1% | 54 | $2K | |
| 96132 | <1% | 13 | $1K | |
| 95874 | <1% | 593 | $1K | |
| 96116 | <1% | 13 | $1K | |
| 96137 | <1% | 13 | $1K | |
| 82435 | <1% | 134 | $1K | |
| 83605 | <1% | 199 | $1K | |
| 64643 | <1% | 15 | $1K | |
| 99417 | Prolong home eval add 15m | <1% | 17 | $1K |
| 97163 | <1% | 33 | $919.09 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 230 | $915.36 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 367 | $794.29 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 111 | $776.94 |
| 85018 | <1% | 449 | $765.90 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 104 | $744.65 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 19 | $733.91 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 13 | $687.55 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 277 | $584.45 |
| 81003 | <1% | 165 | $555.97 | |
| V2632 | Posterior chamber intraocular lens | <1% | 14 | $491.36 |
| 0240U | <1% | 15 | $409.29 | |
| 96136 | <1% | 13 | $388.75 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 158 | $376.39 |
| C1769 | Guide wire | <1% | 74 | $346.54 |
| A9270 | Non-covered item or service | <1% | 1,586 | $212.98 |
| 93320 | <1% | 13 | $210.08 | |
| 97165 | <1% | 13 | $180.43 | |
| 85379 | <1% | 13 | $115.68 | |
| 90686 | <1% | 12 | $84.79 | |
| 82077 | <1% | 14 | $81.90 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 20 | $70.11 |
| 84703 | <1% | 12 | $60.93 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 76 | $53.31 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 31 | $46.26 |
| 86850 | <1% | 18 | $37.66 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 436 | $32.02 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 525 | $31.91 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 31 | $30.75 |
| 86900 | <1% | 17 | $18.54 | |
| 86901 | <1% | 36 | $18.54 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $10.43 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 14 | $6.74 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 0% | 103 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOOS, DAVID (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Allina Health System | Golden Valley, MN | $206K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.